Mostrar el registro sencillo del ítem
Amerindian ancestry influences genetic susceptibility to chronic obstructive pulmonary disease
dc.contributor.author | Díaz-Peña R. | |
dc.contributor.author | Boekstegers F. | |
dc.contributor.author | Silva R.S. | |
dc.contributor.author | Jaime S. | |
dc.contributor.author | Hosgood H.D. | |
dc.contributor.author | III | |
dc.contributor.author | Miravitlles M. | |
dc.contributor.author | Agustí À. | |
dc.contributor.author | Bermejo J.L. | |
dc.contributor.author | Olloquequi J. | |
dc.date.accessioned | 2020-09-02T22:16:51Z | |
dc.date.available | 2020-09-02T22:16:51Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.3390/jpm10030093 | |
dc.identifier.citation | 10, 3, 1-14 | |
dc.identifier.issn | 20754426 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/4356 | |
dc.description | The contribution of genetic ancestry on chronic obstructive pulmonary disease (COPD) predisposition remains unclear. To explore this relationship, we analyzed the associations between 754,159 single nucleotide polymorphisms (SNPs) and risk of COPD (n = 214 cases, 193 healthy controls) in Talca, Chile, considering the genetic ancestry and established risk factors. The proportion of Mapuche ancestry (PMA) was based on a panel of 45 Mapuche reference individuals. Five PRDM15 SNPs and two PPP1R12B SNPs were associate with COPD risk (p = 0.05 to 5×10−4) in those individuals with lower PMA. Based on linkage disequilibrium and sliding window analyses, an adjacent PRDM15 SNPs were associated with COPD risk in the lower PMA group (p = 10−3 to 3.77×10−8). Our study is the first to report an association between PPP1R12B and COPD risk, as well as effect modification between ethnicity and PRDM15 SNPs in determining COPD risk. Our results are biologically plausible given that PPP1R12B and PRDM15 are involved in immune dysfunction and autoimmunity, providing mechanistic evidence for COPD pathogenesis and highlighting the importance to conduct more genome wide association studies (GWAS) in admixed populations with Amerindian descent. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. | |
dc.language.iso | en | |
dc.publisher | MDPI AG | |
dc.subject | Ancestry | |
dc.subject | Autoimmunity | |
dc.subject | Chronic obstructive pulmonary disease (COPD) | |
dc.subject | Genome wide association studies (GWAS) | |
dc.subject | Hispanic paradox | |
dc.subject | Immune dysfunction | |
dc.subject | Personalized medicine | |
dc.subject | genomic DNA | |
dc.subject | aged | |
dc.subject | American Indian | |
dc.subject | Article | |
dc.subject | biomass | |
dc.subject | body mass | |
dc.subject | carbon monoxide diffusing capacity of the lung | |
dc.subject | Chile | |
dc.subject | chronic obstructive lung disease | |
dc.subject | clinical assessment | |
dc.subject | cohort analysis | |
dc.subject | controlled study | |
dc.subject | disease predisposition | |
dc.subject | dyspnea | |
dc.subject | exercise | |
dc.subject | female | |
dc.subject | forced expiratory volume | |
dc.subject | forced vital capacity | |
dc.subject | gene frequency | |
dc.subject | gene linkage disequilibrium | |
dc.subject | genetic association | |
dc.subject | genetic risk | |
dc.subject | genetic susceptibility | |
dc.subject | genome-wide association study | |
dc.subject | genotyping technique | |
dc.subject | hospitalization | |
dc.subject | human | |
dc.subject | lung function | |
dc.subject | lung function test | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | modified medical research council scale | |
dc.subject | oxygen saturation | |
dc.subject | principal component analysis | |
dc.subject | pulse oximetry | |
dc.subject | quality of life | |
dc.subject | risk factor | |
dc.subject | single nucleotide polymorphism | |
dc.subject | six minute walk test | |
dc.subject | smoking | |
dc.title | Amerindian ancestry influences genetic susceptibility to chronic obstructive pulmonary disease | |
dc.type | Article |